Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of Ticagrelor Anti-platelet Effects
NCT02383771Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Mar 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Jiangsu Provincial People's Hospital. Started Mar 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02383771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383771.